Avidity Biosciences, Inc. (DELISTED) (RNAM:DL)
Avidity Biosciences Market Cap : 11.30B for March 6, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Dyne Therapeutics, Inc. | 2.957B |
| Biogen, Inc. | 26.64B |
| BioMarin Pharmaceutical, Inc. | 11.25B |
| Insmed, Inc. | 30.07B |
| Revolution Medicines, Inc. | 18.80B |
Market Cap Related Metrics
| PS Ratio | 530.01 |
| PEG Ratio | -0.2061 |
| Price to Book Value | 6.691 |
| Price | 72.82 |
| Earnings Yield | -6.82% |
| PEGY Ratio | -0.2061 |